Eric J. Sundberg, PhD, is the School of Medicine Endowed Professor and Chair of Biochemistry at the Emory University School of Medicine and an internationally recognized expert in antibody engineering, immune modulation, and protein–glycan interactions. His research has defined core principles governing IgG Fc structure–function relationships, glycosylation-dependent control of antibody-mediated effector functions, and enzymatic remodeling of antibodies.

Dr. Sundberg’s laboratory has made foundational discoveries in IgG-specific endoglycosidases and Fc glycoengineering, revealing previously unrecognized mechanisms of antibody asymmetry and epistasis that directly inform the design of next-generation biologics. These insights have translated into novel therapeutic modalities, including antibody-editing enzymes and engineered antibodies with precisely tuned immune functions.

He is a co-founder and/or board member of multiple biotechnology companies and holds an
extensive patent portfolio licensed for clinical development. Dr. Sundberg brings deep
experience in translational strategy and mechanism-driven product differentiation, bridging
fundamental science and scalable therapeutic innovation.